Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
abundancy, Abzena, afflicted, AP, Argenx, ATM, atropy, attack, autoantibody, Biogn, biomarker, bookrunner, CATALINA, compenent, CP, Curia, cytoplasmic, declassify, delisting, DERBY, Diego, downsize, DVM, extrafoveal, fashion, formalizing, freestanding, FVII, FVIID, Hemab, HS, ID, immunodeficiency, ImmunoTUNE, inflow, IVT, Jeanne, Jew, Knudsen, lab, lifetime, lyophilized, mechanistically, membrane, microthrombotic, Miller, Multifocal, necessitating, Neuropathy, NGM, Nonrefundable, ophthalmic, outplacement, overactivation, overactive, Overview, pegacetacoplan, Piper, poised, prognostic, ProTUNE, provisional, Raymond, rebalanced, remote, reopened, retention, retire, Sandler, Seline, serum, sublease, Subtopic, successor, supervisory, Suppurativa, surface, tenant, thereunder, Tom, topline, upcoming, voucher, warm, workforce, worsening, worth
Removed:
ABR, absent, adjunct, Allied, antigen, Australia, background, bleed, caption, careful, cell, center, clearance, cofactor, computation, contingent, counterparty, elaparvovec, eleven, encouraging, feasibility, fidanacogene, FVIII, Gateway, Haemophilia, hospital, immunogenic, inactivate, indirect, infection, inherit, initiating, interfere, intravenously, Israel, Japan, median, moderate, modifying, mutation, pose, prolonged, prothrombin, randomized, respiratory, responsive, resume, scheduled, sequelae, serving, strive, surgery, thrombotic, trough, underwritten, VIIIa, vitro, Xa
Filing tables
Filing exhibits
GYRE similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Catalyst Biosciences, Inc. on Form S-8 (Nos. 333-133881, 333-133882, 333-160331, 333-185888, 333-189143, 333-206523, 333-206526, 333-212345, 333-219301, 333-225902, and 333-239712), and Form S-3 (Nos. 333-228970 and 333-253874) of our report dated March 31, 2022, on our audits of the financial statements as of December 31, 2021 and 2020, and for each of the years then ended, which report is included in this Annual Report on Form 10-K to be filed on or about March 31, 2022.
/s/ EisnerAmper LLP
EISNERAMPER LLP
Iselin, New Jersey
March 31, 2022